Biosynthesis of BREVIANAMIDE (cas 12634-10-5)s A and B: in search of the biosynthetic diels-alder construction

Add time:08/18/2019    Source:sciencedirect.com

A [13C]labeled hypothetical intermediate metabolite that was invoked by Birch in the biogenesis of brevianamides A and B has been synthesized and used in a biosynthetic feeding experiment. No incorporation of this substance was evident nor could it be detected in culture extracts of the producing organism Penicillium brevicompactum. In contrast with this, [3H]labeled deoxybrevianamide E was shown to be efficiently incorporated in brevianamides A, B, and E, while [3H]labeled brevianamide E was not incorporated at all in these substances. Moreover, brevianamide E has been found not to be an artifact, in contrast with an earlier suggestion found in the literature. These results are discussed in terms of an alternative biosynthetic pathway for the brevianamides.

We also recommend Trading Suppliers and Manufacturers of BREVIANAMIDE (cas 12634-10-5). Pls Click Website Link as below: cas 12634-10-5 suppliers

Prev:Effects of BREVIANAMIDE (cas 12634-10-5) A, its photolysis product BREVIANAMIDE (cas 12634-10-5) D, and ochratoxin A from two Penicillium strains on the insect pests Spodoptera frugiperda and Heliothis virescens
Next:Biomimetic diels–alder cyclizations for the construction of the BREVIANAMIDE (cas 12634-10-5), paraherquamide, sclerotamide, asperparaline and VM55599 ring systems)